Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.46M | Sell |
121,331
-700
| -0.6% | -$54.6K | 0.68% | 27 |
|
2025
Q1 | $8.83M | Buy |
122,031
+770
| +0.6% | +$55.7K | 0.66% | 26 |
|
2024
Q4 | $8.98M | Buy |
121,261
+210
| +0.2% | +$15.5K | 0.59% | 29 |
|
2024
Q3 | $7.99M | Buy |
121,051
+1,844
| +2% | +$122K | 0.47% | 42 |
|
2024
Q2 | $11M | Sell |
119,207
-24,858
| -17% | -$2.3M | 0.7% | 22 |
|
2024
Q1 | $13.8M | Sell |
144,065
-16,486
| -10% | -$1.58M | 0.98% | 19 |
|
2023
Q4 | $12.2M | Buy |
160,551
+19,455
| +14% | +$1.48M | 0.89% | 28 |
|
2023
Q3 | $9.77M | Buy |
141,096
+3,334
| +2% | +$231K | 0.66% | 37 |
|
2023
Q2 | $13M | Buy |
137,762
+8,011
| +6% | +$755K | 0.66% | 26 |
|
2023
Q1 | $10.7M | Sell |
129,751
-2,876
| -2% | -$238K | 0.55% | 32 |
|
2022
Q4 | $9.9M | Buy |
132,627
+37,849
| +40% | +$2.82M | 0.48% | 34 |
|
2022
Q3 | $7.83M | Buy |
94,778
+78,728
| +491% | +$6.51M | 0.5% | 44 |
|
2022
Q2 | $1.53M | Sell |
16,050
-7,237
| -31% | -$688K | 0.12% | 92 |
|
2022
Q1 | $2.74M | Buy |
23,287
+400
| +2% | +$47.1K | 0.22% | 81 |
|
2021
Q4 | $2.97M | Buy |
+22,887
| New | +$2.97M | 0.23% | 92 |
|